CAS 54208-72-9: α-[[(1,1-Dimethylethyl)amino]methyl]-2,2-dimethyl-4H-1,3-benzodioxin-6-methanol

Salbutamol acetonide is a drug substance that belongs to the class of beta-adrenergic receptor agonists and is used as a bronchodilator. It is a prodrug that is hydrolyzed in vivo to salbutamol, its active form. The physicochemical properties of this drug are important for its use in inhalation therapy because it must be delivered as a dry powder or in solid dispersions for maximal efficacy. Salbutamol acetonide can also be formulated into microparticles or particles with different sizes, which may alter the release rate of the drug and potentially provide therapeutic benefits. Salbutamol acetonide has been shown to decrease inflammation, smooth muscle cell proliferation, and mucus hypersecretion in animal experiments. This drug has been used as an endpoint marker in vitro and strategies have been developed to determine the optimal dose of salbutamol acetonide for human use.

Applications Salbutamol Acetonide is a Salbutamol (A514500) derivative. It has higher lipophilicity than Salbutamol, which allows an increase of the incorporation efficiency into solid lipid microparticles (SLMs) drug carrier system. References Jaspart, S. et al.: Eur. J. Pharm. Biopharm., 65, 47 (2007)